Related Experiment Video
Updated: Aug 29, 2026

Formulation and Characterization of Bioactive Agent Containing Nanodisks
Published on: March 17, 2023
Pharmacokinetics of amphotericin B lipid complex in critically ill patients on continuous veno-venous haemofiltration
Romuald Bellmann1, Petra Egger, Angela Djanani
1Clinical Pharmacokinetics Unit, Medical Intensive Care Research Laboratory, University of Innsbruck, Austria. romuald.bellmann@uibk.ac.at
Abstract:
Pharmacokinetics of amphotericin B lipid complex (ABLC) was determined in two critically ill patients requiring continuous veno-venous haemofiltration (CVVH) because of acute renal failure. ABLC was administered at a mean daily dose of 4.94 mg/kg for suspected invasive mycosis. Mean C(max) was 0.56 microg/ml, the mean AUC(0-24 h) was 7.46 mgh/l, V(ss) 9.13 l/kg, and t(1/2) was 13.21 h. The haemofilter clearance accounted about 20% of the total ABLC clearance. In one patient sampling was repeated after CVVH had been discontinued. The concentration-time profiles were very similar on and off haemofiltration. Data on our two patients suggest, that pharmacokinetics of ABLC is not significantly affected by CVVH and that ABLC can be administered at the standard doses during CVVH.
Related Concept Videos
Antifungal Agents
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Estimation of k and VD of Aminoglycosides
Continuous Renal Replacement Therapy
Pharmacokinetics in Pediatric Patients: Drug Excretion
